WALTHAM, Mass. – Glytec’s digital diabetes management software, Glucommander Outpatient, will be integrated with Onduo’s virtual diabetes clinic now in development. The integrated solution will launch in pilot programs with select U.S. providers and payers early next year. Onduo, a joint venture of Sanofi and the Alphabet company Verily, is developing the virtual platform that integrates hardware, such as wirelessly-connected continuous glucose monitors, software and personalized support from healthcare experts to help people manage their Type 2 diabetes. “Roughly half of 7.5 million people in the U.S. who use insulin to manage their diabetes are not reaching their treatment goals, and millions more who could benefit from insulin therapy either avoid it or discontinue it,” said Dr. Andrew Rhinehart, chief medical officer at Glytec, in a statement. “Fixing this decades-old problem represents one of the greatest opportunities to improve the quality and cost of diabetes care.” According to multiple studies involving the use of Glucommander Outpatient in clinical practice, patients reach their glucose targets in an average of 12.5 days and sustain drops in A1C of 2.5 percentage points over a 12-month period, with very low incidence of hypoglycemia.
You are here: / / Glytec diabetes software integrates with Onduo Virtual Clinic